spacer
home > epc > spring 2017 > transforming software
PUBLICATIONS
European Pharmaceutical Contractor

Transforming Software

With the wide-scale adoption of clinical technologies, focus has slowly shifted from ‘how can we leverage new software and systems in our clinical trials?’ to ‘how can we best implement this software once we’ve chosen it?’ In a highly regulated industry, with patient safety and new treatment advances at stake, the priority has historically been compliance and risk management. Now that these systems are mature and reliable, identifying new ways to make them available in a more efficient and timely manner is important. Utilising iterative design is one way to address these needs.

The Triple Constraint

Anyone who has developed software or managed projects is familiar with the triangle concept – any movement of one factor impacts the equilibrium. For example, increasing the complexity of a clinical supply tool is sure to extend time to implement and development costs. Using an iterative approach helps manage these constraints as well as scope, and maintain quality while reducing time and cost.

Innovation to Date


Quality is of paramount importance with a clinical interactive response technology (IRT) system. When patients are being treated and new drugs developed, quality cannot be compromised. This quality profile must be maintained amid increasingly complex protocol designs, shorter timeline requirements and tighter budgets.

Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer

spacer
Steve Rawbone
spacer
spacer
spacer
Stephane Delegar
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

Nanobiotix presents NBTXR3 preclinical data


More info >>

White Papers

eSource: Reducing Site Workload for Better, Faster, Safer Clinical Trials

Clinical Ink

Unlike traditional electronic data capture (EDC), SureSource, Clinical Ink’s eSource platform, was designed from the beginning to minimize clinical trial complexity for site users. A Site Impact Survey provides scientific evidence regarding the impact of SureSource from 517 site users. Results confirm it significantly reduces workload, lessens queries, and improves data quality compared to paper and EDC. In this white paper, we quantitatively evaluate survey outcomes, provide qualitative feedback from survey respondents, and highlight the observed benefits of SureSource for transforming clinical research.
More info >>

 
Industry Events

6th Annual Cancer Vaccines Conference

27-28 September 2017, Copthorne Tara Hotel, London UK

Cancer Vaccines 2017: Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies. SMi Group is thrilled to present the 6th annual Cancer Vaccines conference, taking place on 27th & 28th September 2017 in Central London, UK. Overcoming hurdles to cancer immune response: Cell therapies, vaccine development and combination therapies.
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement